Roundtable discussion title: "The right drug targets for the right patient - Using biomarkers to solve challenges in drug development"

In this roundtable discussion, three pharmaceutical research scientists discuss the past, present, and future of protein biomarker use in the pharmaceutical field, as well as opportunities and challenges in using biomarker data in drug discovery and development.

Find out more:

Watch Dr. Jurgen Braunger of Boehringer Ingelheim, Dr. Timothy Radstake of AbbVie, and Dr. Chris Whelan of Biogen discuss:

• The history of biomarker research in their organisations as well as challenges they have faced in their drug development.
• How protein biomarkers can drive clinical trials and how it has been used in their own drug development research.
• The challenges pharmaceutical researchers face in implementing the use of protein biomarkers in their research, and how the field will evolve to meet these challenges.

Speakers